From: Predictors of COVID-19 outcome in type 2 diabetes mellitus: a hospital-based study
Univariate analysis | Multivariate analysis | |||||||
---|---|---|---|---|---|---|---|---|
p value | OR | 95%CI | p value | OR | 95%CI | |||
Age | 0.022* | 1.039 | 1.005 | 1.073 | ||||
Sex | 0.589 | 0.783 | 0.322 | 1.904 | ||||
HbA1c | 0.011* | 1.227 | 1.048 | 1.436 | ||||
Comorbidities | 0.005* | 8.667 | 1.950 | 38.521 | ||||
Complications | 0.000* | 6.401 | 2.509 | 16.330 | ||||
Hospital stay | 0.005* | 1.073 | 1.021 | 1.128 | ||||
ICU admission | 0.000* | 44.118 | 9.480 | 205.309 | 0.04* | 223.2 | 2.09 | 2386.7 |
Smoking | 0.599 | 1.479 | .343 | 6.376 | ||||
Residence | 0.998 | 0.75 | 0.66 | 1.86 | ||||
BMI | 0.381 | 1.036 | .958 | 1.120 | ||||
Lymphocyte | 0.117 | .657 | .389 | 1.111 | ||||
neutrophile | 0.002* | 1.181 | 1.061 | 1.315 | ||||
D-dimer | 0.001* | 1.659 | 1.225 | 2.248 | ||||
CRP | < 0.001* | 1.026 | 1.013 | 1.038 | ||||
Ferritin | 0.200 | 1.001 | .999 | 1.003 |